scispace - formally typeset
D

Daniel Prieto-Alhambra

Researcher at University of Oxford

Publications -  438
Citations -  11189

Daniel Prieto-Alhambra is an academic researcher from University of Oxford. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 45, co-authored 345 publications receiving 7269 citations. Previous affiliations of Daniel Prieto-Alhambra include Erasmus University Medical Center & Mount Vernon Hospital.

Papers
More filters
Journal ArticleDOI

Early (1-year) Discontinuation of Different Anti-osteoporosis Medications Compared: A Population-Based Cohort Study

TL;DR: Monthly risedronate, weekly alendronsate, and daily teriparatide are the drugs with the best persistence, whilst daily oral drugs have 40–60 % higher first-year discontinuation rates compared toweekly alendronate.
Journal ArticleDOI

Knee arthroplasty and risk of hip fracture: a population-based case-control study

TL;DR: KAs are associated with a 54% increased risk of hip fracture, in particular among adult patients aged <71 years old, and a strong effect modification by age in these patients is found: the youngest patients were at more increased risk for hip fracture.
Journal ArticleDOI

Impact of Rheumatoid Arthritis and Its Management on Falls, Fracture and Bone Mineral Density in UK Biobank.

TL;DR: Investigating associations between RA, RA medications and bone mineral density, falls and fractures, using UK Biobank data found that RA was associated with lower eBMD, increased falls and fracture and Corticosteroid and DMARD therapy, but not biologic therapy, were associated with higher e BMD.
Journal ArticleDOI

Inappropriate opioid dispensing in patients with knee and hip osteoarthritis: a population-based cohort study

TL;DR: More than half the incident opioid dispensations to patients within their first year after knee or hip OA diagnosis are inappropriate according to current treatment guidelines.